Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infection following foot and ankle surgery : a subanalysis of data captured from the UK Foot and Ankle Thromboembolism (FATE) audit.

The bone & joint journal·2026
Same author

Postoperative pain after dental procedures: The National Dental Practice-Based Research Network observational study using an mobile health platform.

Journal of the American Dental Association (1939)·2026
Same author

Performance and Wellbeing Research Priorities in Premiership Women's Rugby: A Delphi Study Including Players and Staff.

European journal of sport science·2025
Same author

Design, manufacture and evaluation of an offloading 3D printed wheelchair cushion.

Disability and rehabilitation. Assistive technology·2025
Same author

Clinical and cost-effectiveness of flexor digitorum profundus (FDP) versus FDP and flexor digitorum superficialis (FDS) repair for complete zone 2 flexor tendon injuries (FLARE): protocol for a randomised controlled trial.

Trials·2025
Same author

The safety and efficacy of left atrial appendage closure devices in patients with non-traumatic intracranial hemorrhage.

Journal of the neurological sciences·2025
Same journal

Refining evidence-based care for diverse bicuspid aortic valve phenotypes: addressing one piece of a larger puzzle.

Heart (British Cardiac Society)·2026
Same journal

No pain, no gain? The complexity of ST-elevation myocardial infarction without chest pain.

Heart (British Cardiac Society)·2026
Same journal

Is earlier better? Re-examining the timing of double sequential external defibrillation.

Heart (British Cardiac Society)·2026
Same journal

Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial.

Heart (British Cardiac Society)·2026
Same journal

Correspondence on 'When a patent foramen ovale becomes pathological' by Saji and Ohara.

Heart (British Cardiac Society)·2026
Same journal

Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.

Heart (British Cardiac Society)·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K

Left atrial appendage occlusion.

Oluseun Alli1, David Holmes1

  • 1The Division of Cardiovascular Diseases and Department of Internal Medicine, University of Alabama, Birmingham, Alabama, USA The Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.

Heart (British Cardiac Society)
|December 19, 2014
PubMed
Summary
This summary is machine-generated.

Left atrial appendage (LAA) occlusion is a promising stroke prevention strategy for atrial fibrillation (AF) patients. While safe and effective, more data is needed for widespread adoption.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.6K

Related Experiment Videos

Last Updated: Apr 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.6K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • Atrial fibrillation (AF) poses a significant risk of stroke and thromboembolism.
  • The left atrial appendage (LAA) is a primary source of thrombus formation in AF patients.
  • Current management focuses on pharmacological stroke prevention, with LAA occlusion as an alternative.

Purpose of the Study:

  • To review the current status of LAA occlusion for stroke prevention in AF.
  • To analyze existing clinical data, available techniques, and devices.
  • To discuss challenges and future directions for LAA occlusion strategies.

Main Methods:

  • Review of current clinical data and randomized trials on LAA occlusion.
  • Analysis of various percutaneous and surgical LAA occlusion devices and techniques.
  • Evaluation of safety, efficacy, cost-effectiveness, and long-term outcomes.

Main Results:

  • LAA occlusion is demonstrated to be a safe and effective stroke prevention method.
  • Challenges to adoption include limited randomized trial data, cost-effectiveness concerns, and procedural risks.
  • Various percutaneous and surgical devices are available for LAA exclusion.

Conclusions:

  • LAA occlusion is a viable alternative for stroke prevention in select AF patients.
  • Further high-quality clinical trial data is essential to support broader adoption.
  • Addressing cost-effectiveness and long-term outcomes will be crucial for future development.